Does 23andMe ' s decline show genetic-based medicine has been overhyped?

23andMe ' s DNA test was once named " invention of the year " , but now the company is in dire financial straits. Is this a sign that genetically based medicine ' s promise has been exaggerated?

Source: New Scientist - Health - March 1, 2024 Category: Consumer Health News Source Type: research